This inventor holds 1 USPTO granted patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Eric Smith - Innovator in Antibody Development
Introduction
Eric Smith is a notable inventor in the field of biotechnology, particularly recognized for his contributions to antibody development. He currently works at Regeneron Pharmaceuticals, Inc., where he focuses on innovative solutions in medical science. His work has significant implications for therapeutic applications.
Latest Patents
Eric Smith holds a patent for "Bispecific Anti-MUC16 x Anti-CD28 Antibodies and Uses Thereof." This invention represents a significant advancement in the treatment of various diseases, showcasing his expertise in the field.
Career Highlights
Throughout his career, Eric has demonstrated a commitment to advancing medical technology. His work at Regeneron Pharmaceuticals, Inc. has positioned him as a key player in the development of novel therapeutic antibodies.
Collaborations
Eric collaborates with talented professionals, including his coworker Dimitris Skokos. Together, they contribute to groundbreaking research and development efforts within their organization.
Conclusion
Eric Smith's innovative work in antibody development exemplifies the impact of dedicated inventors in the biotechnology sector. His contributions continue to shape the future of medical treatments and therapies.